Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 202208-07-2022
08-07-2022
Laurus Labs Ltd - 540222 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0770 Name of the Signatory :- G Venkateswar ReddyDesignation :- Company Secretary and Compliance Officer08-07-2022
Laurus Labs Ltd - 540222 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Laurus Labs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-07-2022
Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed the voting results (Annexure A) of the Resolutions passed in the 17th Annual general Meeting held on June 30, 2022 along with Scrutinizer Report (Annexure B) on voting (remote e-voting and e-voting at the Meeting).30-06-2022
Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed the summary of the proceedings of the 17th Annual General Meeting held on June 30, 2022.30-06-2022
Laurus Labs Ltd - 540222 - Grant Of Stock Options To The Eligible Employees
In terms of the applicable provisions of SEBI (LODR) Regulations, 2015, we wish to inform you that, the Nomination and Remuneration Committee of the Board of Directors of the Company has approved the grant of 2,70,750 stock options of the face value of Rs.2/- each ('options') at the grant price of Rs. 350.00/- (Rupees Three hundred and fifty only) (i.e. 25% less than the Market Value of the Share on the last trading day, i.e., June 29, 2022) to 349 eligible employees of the Company under 'LAURUS EMPLOYEES STOCK OPTION SCHEME 2016' (Grant-III) and 5,000 stock options of the face value of Rs.2/- each ('options') at the grant price of Rs. 350.00/- (Rupees Three hundred and fifty only) to 1 eligible employee of the subsidiary Company under 'LAURUS EMPLOYEES STOCK OPTION SCHEME 2018' (Grant-III). The effective date of Grants is April 01, 2022.30-06-2022
Laurus Labs Ltd - 540222 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of the Company shall remain closed :from July 01, 2022 till 48 hours after the declaration of un-audited financial results for the quarter ended June 30, 2022. The date of Board Meeting of the Company for consideration and approval of the un-audited financial results for the quarter ended June 30, 2022 will be intimated later. This is for your information and records.29-06-2022
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 201520-06-2022
Laurus Labs: Synthesis business fortifies growth outlook
Relatively better growth visibility and the recent steps towards diversification support our long-term conviction on this scrip.15-06-2022
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations 201513-06-2022